HUP0000783A2 - N-(piridinil-amino)-izoindolinok és származékaik, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents
N-(piridinil-amino)-izoindolinok és származékaik, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásukInfo
- Publication number
- HUP0000783A2 HUP0000783A2 HU0000783A HUP0000783A HUP0000783A2 HU P0000783 A2 HUP0000783 A2 HU P0000783A2 HU 0000783 A HU0000783 A HU 0000783A HU P0000783 A HUP0000783 A HU P0000783A HU P0000783 A2 HUP0000783 A2 HU P0000783A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- carbon atoms
- formula
- hydrogen atom
- alkyl group
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- FRDNVRYBEXCNBP-UHFFFAOYSA-N n-pyridin-2-yl-1,3-dihydroisoindol-2-amine Chemical class C1C2=CC=CC=C2CN1NC1=CC=CC=N1 FRDNVRYBEXCNBP-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 8
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
A találmány tárgya az (1) általános képletű vegyület, ahol azáltalános képletben R jelentése hidrogénatom, valamely R2O- képletű csoport, ahol R2jelentése hidrogénatom, 1-6 szénatomszámú alkilcsoport, benzilcsoportvagy valamely (R3)3Si- képletű csoport, ahol R3 jelentése 1-6szénatomszámú alkilcsoport vagy valamely R4R5NCO- képletű csoport,ahol R4 és R5 jelentése egymástól függetlenül hidrogénatom, 1-6szénatomszámú alkilcsoport vagy benzilcsoport; R4 és R5 a kapcsolódónitrogénatommal valamely (a) vagy (b) képletű csoportot képez; R1 jelentése hidrogénatom vagy 1-6 szénatomszámú alkilcsoport; X jelentése hidrogénatom, 1-6 szénatomszámú alkilcsoport, halogénatom,hidroxilcsoport, 1-6 szénatomszámú alkoxicsoport vagy trifluor-metil-csoport; Y jelentése hidrogénatom, 1-6 szénatomszámú alkilcsoport, halogénatom,hidroxilcsoport, 1-6 szénatomszámú alkoxicsoport vagy trifluor-metil-csoport; m jelentése 1 vagy 2; n jelentése 1, 2 vagy 3; p jelentése 1 vagy 2; annak optikai izomerjei vagy gyógyászatilagelfogadható sói. A találmány magában foglalja az (I) általános képletűvegyületek előállítási eljárását is. A találmány szerinti vegyületekmemóriajavító és depresszióellenes hatással rendelkeznek. Ó
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77430896A | 1996-12-27 | 1996-12-27 | |
US08/959,789 US6004977A (en) | 1996-12-27 | 1997-10-29 | N-(pyridinylamino) isoindolines and related compounds |
PCT/US1997/020591 WO1998029407A2 (en) | 1996-12-27 | 1997-11-13 | N-(pyridinylamino)isoindolines for treating alzheimer's and depression |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0000783A2 true HUP0000783A2 (hu) | 2001-04-28 |
Family
ID=27118867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0000783A HUP0000783A2 (hu) | 1996-12-27 | 1997-11-13 | N-(piridinil-amino)-izoindolinok és származékaik, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0950056B1 (hu) |
JP (1) | JP4256937B2 (hu) |
KR (1) | KR20000062358A (hu) |
AT (1) | ATE224387T1 (hu) |
AU (1) | AU720466B2 (hu) |
BR (1) | BR9714189A (hu) |
CA (1) | CA2276203C (hu) |
DE (1) | DE69715668T2 (hu) |
DK (1) | DK0950056T3 (hu) |
ES (1) | ES2179377T3 (hu) |
HU (1) | HUP0000783A2 (hu) |
IL (1) | IL130642A0 (hu) |
NO (1) | NO993180L (hu) |
PT (1) | PT950056E (hu) |
WO (1) | WO1998029407A2 (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6772195B1 (en) | 1999-10-29 | 2004-08-03 | Electronic Arts, Inc. | Chat clusters for a virtual world application |
AU2001256733A1 (en) * | 2000-05-16 | 2001-11-26 | Takeda Chemical Industries Ltd. | Melanin-concentrating hormone antagonist |
KR20060009686A (ko) * | 2004-07-26 | 2006-02-01 | 엘지이노텍 주식회사 | 반도체 발광소자 및 그 제조방법 |
CA2676066C (en) | 2007-01-22 | 2016-06-28 | Gtx, Inc. | Nuclear receptor binding agents |
US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0287982B1 (en) * | 1987-04-24 | 1994-12-07 | Hoechst-Roussel Pharmaceuticals Incorporated | N-(Pyridinyl)-1H-indol-1-amines, a process for their preparation and their use as medicaments |
US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
EP0415103B1 (en) * | 1989-08-02 | 1995-02-01 | Hoechst-Roussel Pharmaceuticals Incorporated | 2,3-Dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments |
US5102891A (en) * | 1990-07-23 | 1992-04-07 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates |
US5177088A (en) * | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
US5328920A (en) * | 1991-04-17 | 1994-07-12 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted (pyridinylamino)-indoles |
-
1997
- 1997-11-13 WO PCT/US1997/020591 patent/WO1998029407A2/en active IP Right Grant
- 1997-11-13 DK DK97948250T patent/DK0950056T3/da active
- 1997-11-13 KR KR1019997005846A patent/KR20000062358A/ko active IP Right Grant
- 1997-11-13 CA CA002276203A patent/CA2276203C/en not_active Expired - Fee Related
- 1997-11-13 DE DE69715668T patent/DE69715668T2/de not_active Expired - Fee Related
- 1997-11-13 AU AU54349/98A patent/AU720466B2/en not_active Ceased
- 1997-11-13 ES ES97948250T patent/ES2179377T3/es not_active Expired - Lifetime
- 1997-11-13 JP JP52999098A patent/JP4256937B2/ja not_active Expired - Fee Related
- 1997-11-13 EP EP97948250A patent/EP0950056B1/en not_active Expired - Lifetime
- 1997-11-13 IL IL13064297A patent/IL130642A0/xx unknown
- 1997-11-13 AT AT97948250T patent/ATE224387T1/de not_active IP Right Cessation
- 1997-11-13 BR BR9714189-5A patent/BR9714189A/pt not_active IP Right Cessation
- 1997-11-13 PT PT97948250T patent/PT950056E/pt unknown
- 1997-11-13 HU HU0000783A patent/HUP0000783A2/hu unknown
-
1999
- 1999-06-25 NO NO993180A patent/NO993180L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2179377T3 (es) | 2003-01-16 |
DE69715668D1 (de) | 2002-10-24 |
ATE224387T1 (de) | 2002-10-15 |
WO1998029407A3 (en) | 1998-10-22 |
EP0950056B1 (en) | 2002-09-18 |
NO993180L (no) | 1999-08-26 |
WO1998029407A2 (en) | 1998-07-09 |
DE69715668T2 (de) | 2003-07-31 |
KR20000062358A (ko) | 2000-10-25 |
EP0950056A2 (en) | 1999-10-20 |
NO993180D0 (no) | 1999-06-25 |
CA2276203C (en) | 2003-07-22 |
AU720466B2 (en) | 2000-06-01 |
BR9714189A (pt) | 2000-02-29 |
CA2276203A1 (en) | 1998-07-09 |
PT950056E (pt) | 2002-12-31 |
DK0950056T3 (da) | 2003-01-27 |
JP4256937B2 (ja) | 2009-04-22 |
JP2001511119A (ja) | 2001-08-07 |
IL130642A0 (en) | 2000-06-01 |
AU5434998A (en) | 1998-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW369526B (en) | Diazabicyclic neurokinin antagonists | |
HUP0002112A2 (hu) | Helyettesített 3-ciano-kinolinok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
HUP9802694A1 (hu) | Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
AU7291796A (en) | 8-azabicyclo{3.2.1}oct-2-ene derivatives, their preparation and use | |
MY111616A (en) | Nover (r)-5-carbamoyl-8-fluoro-3-n, n-disubstituted-amino-3, 4-dihydro-2h-1-benzopyrans | |
NZ331613A (en) | Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
DE3876813D1 (de) | 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a. | |
TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
CA2176935A1 (fr) | Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d | |
BG100883A (en) | Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors | |
HUP0001165A2 (hu) | NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra | |
TW252114B (hu) | ||
HUP0000783A2 (hu) | N-(piridinil-amino)-izoindolinok és származékaik, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ES2027550A6 (es) | Procedimiento para preparar derivados de glicerol. | |
DK0383686T3 (da) | Carboxyalkylethere af 2-amino-7-hydroxytetralin samt fremgangsmåde til fremstilling deraf | |
EA199600007A2 (ru) | Новые трициклические производные, способ их получения, способы получения оптически активных или рацемических колхицина и тиоколхицина, их аналогов или производных с использованием трициклических соединений и промежуточные продукты синтеза | |
MY131544A (en) | Fluorinated 4-aminoandrostadienone derivatives and process for their preparation | |
HUP0102447A2 (hu) | Új oktahidro-6,10-dioxo-6H-piridazino[1,2-a][1,2]diazepin-1-karbonsav-származékok, eljárás a vegyületek előállítására és alkalmazásuk gyógyászati hatóanyagok előállítására | |
MXPA04002838A (es) | Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
AU5674894A (en) | Azanoradamantanes | |
HUP0204444A2 (en) | Phenyl- and pyridyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them | |
HU886767D0 (en) | Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients | |
ES8403866A1 (es) | Un metodo de producir un derivado de 4-ciano-2-azetidinona. | |
CA2040489A1 (en) | 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments | |
GB2245566A (en) | Carbamoyl derivatives of alkanolamines and antistress-action agent for plant-growth regulation based thereon |